DYADIC INTERNATIONAL INC Cost of Revenue
DYADIC INTERNATIONAL INC (DYAI) reported Cost of Revenue of $984.16 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Expense Statement
us-gaap:CostOfGoodsAndServicesSold · last filed 2026-08-12
- DYADIC INTERNATIONAL INC cost of goods and services sold for the quarter ending 2026-06-30 was $984.16K, a 60.39% increase year-over-year.
- DYADIC INTERNATIONAL INC cost of goods and services sold for the quarter ending 2026-03-31 was $791.84K, a 166.02% increase year-over-year.
- DYADIC INTERNATIONAL INC cost of goods and services sold for the quarter ending 2025-12-31 was $384.61K, a 9.01% increase year-over-year.
- DYADIC INTERNATIONAL INC cost of goods and services sold for the quarter ending 2025-09-30 was $1.02M, a 158.66% increase year-over-year.
- DYADIC INTERNATIONAL INC cost of goods and services sold for fiscal 2025 was $2.32M, a 94.19% increase from fiscal 2024.
- DYADIC INTERNATIONAL INC cost of goods and services sold for fiscal 2024 was $1.19M, a 39.54% decline from fiscal 2023.
- DYADIC INTERNATIONAL INC cost of goods and services sold for fiscal 2023 was $1.98M, a 6.94% decline from fiscal 2022.
- DYADIC INTERNATIONAL INC cost of goods and services sold for fiscal 2022 was $2.12M, a 9.19% increase from fiscal 2021.
| Period end | Cost of Goods and Services Sold 3 month | Cost of Goods and Services Sold 3 month as first filed | Cost of Goods and Services Sold 6 month | Cost of Goods and Services Sold 9 month | Cost of Goods and Services Sold 12 month |
|---|---|---|---|---|---|
| 2026-06-30 | $984.16K 10-Q · filed 2026-08-12 | $1.78M 10-Q · filed 2026-08-12 | $2.16M derived: sum of 3 quarters · filed 2026-08-12 | $3.18M derived: sum of 4 quarters · filed 2026-08-12 | |
| 2026-03-31 | $791.84K 10-Q · filed 2026-05-13 | $1.18M derived: sum of 2 quarters · filed 2026-05-13 | $2.20M derived: sum of 3 quarters · filed 2026-05-13 | $2.81M derived: sum of 4 quarters · filed 2026-08-12 | |
| 2025-12-31 | $384.61K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-25 | $1.41M derived: sum of 2 quarters · filed 2026-03-25 | $2.02M derived: sum of 3 quarters · filed 2026-08-12 | $2.32M 10-K · filed 2026-03-25 | |
| 2025-09-30 | $1.02M 10-Q · filed 2025-11-12 | $1.64M derived: sum of 2 quarters · filed 2026-08-12 | $1.94M 10-Q · filed 2025-11-12 | $2.29M derived: sum of 4 quarters · filed 2026-08-12 | |
| 2025-06-30 | $613.59K 10-Q · filed 2026-08-12 | $911.25K 10-Q · filed 2026-08-12 | $1.26M derived: sum of 3 quarters · filed 2026-08-12 | $1.66M derived: sum of 4 quarters · filed 2026-08-12 | |
| 2025-03-31 | $297.66K 10-Q · filed 2026-05-13 | $650.48K derived: sum of 2 quarters · filed 2026-05-13 | $1.05M derived: sum of 3 quarters · filed 2026-05-13 | $1.35M derived: sum of 4 quarters · filed 2026-05-13 | |
| 2024-12-31 | $352.82K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-25 | $748.71K derived: sum of 2 quarters · filed 2026-03-25 | $1.05M derived: sum of 3 quarters · filed 2026-03-25 | $1.19M 10-K · filed 2026-03-25 | |
| 2024-09-30 | $395.89K 10-Q · filed 2025-11-12 | $697.85K derived: sum of 2 quarters · filed 2025-11-12 | $841.80K 10-Q · filed 2025-11-12 | $1.19M derived: sum of 4 quarters · filed 2025-11-12 | |
| 2024-06-30 | $301.96K 10-Q · filed 2024-08-13 | $445.91K 10-Q · filed 2024-08-13 | $796.03K derived: sum of 3 quarters · filed 2025-03-26 | $901.90K derived: sum of 4 quarters · filed 2025-03-26 | |
| 2024-03-31 | $143.96K 10-Q · filed 2024-05-14 | $494.07K derived: sum of 2 quarters · filed 2025-03-26 | $599.94K derived: sum of 3 quarters · filed 2025-03-26 | $1.39M derived: sum of 4 quarters · filed 2025-03-26 | |
| 2023-12-31 | $350.12K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-26 | $455.99K derived: sum of 2 quarters · filed 2025-03-26 | $1.25M derived: sum of 3 quarters · filed 2025-03-26 | $1.98M 10-K · filed 2025-03-26 | |
| 2023-09-30 | $105.87K 10-Q · filed 2024-11-12 | $898.81K derived: sum of 2 quarters · filed 2024-11-12 | $1.63M 10-Q · filed 2024-11-12 | $2.33M derived: sum of 4 quarters · filed 2024-11-12 | |
| 2023-06-30 | $792.94K 10-Q · filed 2024-08-13 | $1.52M 10-Q · filed 2024-08-13 | $2.22M derived: sum of 3 quarters · filed 2024-08-13 | $2.83M derived: sum of 4 quarters · filed 2024-08-13 | |
| 2023-03-31 | $726.92K 10-Q · filed 2024-05-14 | $1.43M derived: sum of 2 quarters · filed 2024-05-14 | $2.03M derived: sum of 3 quarters · filed 2024-05-14 | $2.45M derived: sum of 4 quarters · filed 2024-05-14 | |
| 2022-12-31 | $704.49K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-28 | $1.31M derived: sum of 2 quarters · filed 2024-03-28 | $1.72M derived: sum of 3 quarters · filed 2024-03-28 | $2.12M 10-K · filed 2024-03-28 | |
| 2022-09-30 | $602.85K 10-Q · filed 2023-11-08 | $1.01M derived: sum of 2 quarters · filed 2023-11-08 | $1.42M 10-Q · filed 2023-11-08 | $1.75M derived: sum of 4 quarters · filed 2023-11-08 | |
| 2022-06-30 | $411.11K 10-Q · filed 2023-08-09 | $815.86K 10-Q · filed 2023-08-09 | $1.15M derived: sum of 3 quarters · filed 2023-08-09 | $1.54M derived: sum of 4 quarters · filed 2023-08-09 | |
| 2022-03-31 | $404.75K 10-Q · filed 2023-05-10 | $404.75M 10-Q · filed 2022-05-12 | $736.37K derived: sum of 2 quarters · filed 2023-05-10 | $1.13M derived: sum of 3 quarters · filed 2023-05-10 | $1.96M derived: sum of 4 quarters · filed 2023-05-10 |
| 2021-12-31 | $331.63K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-29 | $724.17K derived: sum of 2 quarters · filed 2023-03-29 | $1.55M derived: sum of 3 quarters · filed 2023-03-29 | $1.94M 10-K · filed 2023-03-29 | |
| 2021-09-30 | $392.54K 10-Q · filed 2022-11-10 | $1.22M derived: sum of 2 quarters · filed 2022-11-10 | $1.61M 10-Q · filed 2022-11-10 | $392.24M derived: sum of 4 quarters · filed 2022-11-10 | |
| 2021-06-30 | $829.50K 10-Q · filed 2022-08-10 | $1.22M 10-Q · filed 2022-08-10 | $391.85M derived: sum of 3 quarters · filed 2022-08-10 | $392.11M derived: sum of 4 quarters · filed 2022-08-10 | |
| 2021-03-31 | $390.76M 10-Q · filed 2022-05-12 | $390.76K 10-Q · filed 2021-05-13 | $391.02M derived: sum of 2 quarters · filed 2022-05-12 | $391.28M derived: sum of 3 quarters · filed 2022-05-12 | $391.91M derived: sum of 4 quarters · filed 2022-05-12 |
| 2020-12-31 | $255.58K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-29 | $522.51K derived: sum of 2 quarters · filed 2022-03-29 | $1.15M derived: sum of 3 quarters · filed 2022-03-29 | $1.42M 10-K · filed 2022-03-29 | |
| 2020-09-30 | $266.93K 10-Q · filed 2021-11-10 | $891.17K derived: sum of 2 quarters · filed 2021-11-10 | $1.17M 10-Q · filed 2021-11-10 | $1.59M derived: sum of 4 quarters · filed 2021-11-10 | |
| 2020-06-30 | $624.24K 10-Q · filed 2021-08-12 | $902.42K 10-Q · filed 2021-08-12 | $1.33M derived: sum of 3 quarters · filed 2021-08-12 | $1.71M derived: sum of 4 quarters · filed 2021-08-12 | |
| 2020-03-31 | $278.18K 10-Q · filed 2021-05-13 | $702.95K derived: sum of 2 quarters · filed 2021-05-13 | $1.09M derived: sum of 3 quarters · filed 2021-05-13 | $1.41M derived: sum of 4 quarters · filed 2021-05-13 | |
| 2019-12-31 | $424.77K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-30 | $809.57K derived: sum of 2 quarters · filed 2021-03-30 | $1.13M derived: sum of 3 quarters · filed 2021-03-30 | $1.46M 10-K · filed 2021-03-30 | |
| 2019-09-30 | $384.80K 10-Q · filed 2020-11-12 | $707.03K derived: sum of 2 quarters · filed 2020-11-12 | $1.03M 10-Q · filed 2020-11-12 | $1.54M derived: sum of 4 quarters · filed 2020-11-12 | |
| 2019-06-30 | $322.23K 10-Q · filed 2020-08-13 | $650.13K 10-Q · filed 2020-08-13 | $1.16M derived: sum of 3 quarters · filed 2020-08-13 | $1.40M derived: sum of 4 quarters · filed 2020-08-13 | |
| 2019-03-31 | $327.90K 10-Q · filed 2020-05-14 | $835.85K derived: sum of 2 quarters · filed 2020-05-14 | $1.08M derived: sum of 3 quarters · filed 2020-05-14 | $1.21M derived: sum of 4 quarters · filed 2020-05-14 | |
| 2018-12-31 | $507.95K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-30 | $751.35K derived: sum of 2 quarters · filed 2020-03-30 | $880.47K derived: sum of 3 quarters · filed 2020-03-30 | $1.03M 10-K · filed 2020-03-30 | |
| 2018-09-30 | $243.41K 10-Q · filed 2019-11-13 | $372.52K derived: sum of 2 quarters · filed 2019-11-13 | $519.33K 10-Q · filed 2019-11-13 | ||
| 2018-06-30 | $129.12K 10-Q · filed 2019-08-13 | $275.93K 10-Q · filed 2019-08-13 | |||
| 2018-03-31 | $146.81K 10-Q · filed 2019-05-09 | ||||
| 2017-12-31 | $680.20K 10-K · filed 2019-03-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BioCardia, Inc. (BCDA) | United States | $0.016B | |
| Passage BIO, Inc. (PASG) | United States | $0.015B | -0.43 |
| Pluri Inc. (PLUR) | $0.014B | ||
| INTENSITY THERAPEUTICS, INC. (INTS) | United States | $0.013B | -1.08 |
| BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | United States | $0.013B | -1.05 |
| Jasper Therapeutics, Inc. (JSPR) | United States | $0.020B | -0.37 |
| IN8BIO, INC. (INAB) | United States | $0.012B | -0.76 |
| Estrella Immunopharma, Inc. (ESLA) | United States | $0.020B | |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |